"iDoctor – Medical Blog"

Publication year: 2009<br><b>Source:</b> The American Journal of Cardiology, Volume 104, Issue 10, Supplement 1, 16 November 2009, Pages 52E-57E<br>Michael H., Davidson , Robert S., Rosenson<br><br>As the significance of treating coronary artery disease (CAD) remains a high priority in reducing morbidity and mortality worldwide, newer treatment strategies continue to evolve. The efficacy of statin therapy in reducing low-density lipoprotein cholesterol and reducing cardiovascular events is well established. Yet, addressing residual macrovascular risk becomes a compelling rationale for proposing that pharmacologic therapy targeted at low concentrations of high-density lipoprotein (HDL) cholesterol is a rationale target for enhanced management of CAD. This article reviews current options for the therapeutic manag

This entry was posted on Thursday, November 5th, 2009 at 3:15 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.